PetMed Express, Inc. (PETS)

NASDAQ: PETS · USD

$1.19

+0.01 (+0.8%)· Recorded snapshot

Market cap	25.1M
Revenue (ttm)	168.9M
Net income (ttm)	-29.3M
EPS (ttm)	-$1.38
Shares out	21.1M
Volume	18,743
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 168.9M
Net income (ttm): -29.3M
EPS (ttm): -$1.38
Market cap: 25.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.6

P25 n/aP50 n/aP75 n/a

ROIC-302.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PETS indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001040130
Company name	PetMed Express, Inc.
Country	United States
Country code	US
CUSIP number	716382106
Earnings date	2026-11-10
Earnings time	amc
Employees	189
Employees change	16
Employees growth	9.25%
Enterprise value	$12.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	1996
Industry	Pharmaceutical Retailers
Is primary listing	Yes
Is SPAC	No
ISIN number	US7163821066
Last 10-K release date	2026-06-02
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	1999-03-04
Last stock split type	Forward
Market cap	$25.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.19
Price currency	USD
Sector	Healthcare
SIC code	5912
Stock price date	2026-10-28
Symbol	PETS
U.S. state	Florida
Website	https://www.1800petmeds.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.97x
Earnings yield	-116.32%
EV/Sales	0.07x
FCF / EV yield	-228.1%
FCF yield	-111.8%
P/B ratio	1.08x
P/S ratio	0.15x
Price / tangible book value	1.4x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-16.49%
EBITDA margin	-11.01%
Gross margin	27.92%
Operating margin	-16.49%
Pretax margin	-17.38%
Profit margin	-17.34%
Profit per employee	$-154,915
Revenue per employee	$893,418
ROA	-20.05%
ROA (5Y)	-2.06%
ROCE	-120.19%
ROE	-78.56%
ROE (5Y)	-19.2%
ROIC	-302.82%
ROIC (5Y)	-6.53%
SBC / revenue	0.58%
Tax / revenue	-0.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	-26.91%
Gross profit growth (Q)	-21.32%
Gross profit growth 3Y	-13.74%
Gross profit growth 5Y	-11.11%
Net income growth quarters	2
Net income growth years	0
Revenue growth	-20.33%
Revenue growth (Q)	-19.86%
Revenue growth (QoQ)	-4.21%
Revenue growth 10Y	-3.27%
Revenue growth 3Y	-13.93%
Revenue growth 5Y	-10.4%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4M
Depreciation and amortization	$9.3M
EBIT	$-27.8M
EBITDA	$-18.6M
EPS	$-1.38
FCF per share	$-1.32
Financing cash flow	$-274,000
Free cash flow	$-27.8M
Free cash flow minus SBC	$-28.7M
Gross profit	$47.1M
Income taxes	$-69,000
Investing cash flow	$-4M
Net cash flow	$-28M
Net income	$-29.3M
Operating cash flow minus SBC	$-24.8M
Operating income	$-27.8M
Revenue	$168.9M
Stock-based compensation	$972,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.85
Book value per share	$1.09
Debt / equity	0.02
Interest coverage	-198.86
Long-term assets	$36.2M
Long-term liabilities	$175,000
Net cash (debt)	$12.7M
Net cash / market cap	50.98%
Net cash growth	-68.53%
Net debt / equity	-0.55
Piotroski F-Score	2
Property, plant and equipment	$25.6M
Shareholders' equity	$23M
Tangible book value	$17.7M
Tangible book value per share	$0.84
Total assets	$63.8M
Total cash	$13.1M
Total debt	$414,000
Total liabilities	$40.8M
WACC	9.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.95
Current assets	$27.6M
Current liabilities	$40.6M
Current ratio	0.68
Inventory turnover	9.07
Net working capital	$-25.7M
Quick ratio	0.36
Working capital	$-13M
Working capital turnover	-124.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.4%
Dividend growth (10Y)	6.83%
Dividend growth (3Y)	2.94%
Dividend growth (5Y)	4.35%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.30
Shareholder yield	-2.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-93.95%
10Y return CAGR	-22.13%
10Y total return	-91.8%
150-day SMA	$1.88
15Y price change	-88.63%
15Y return CAGR	-9.8%
15Y total return	-78.72%
1D price change	0.85%
1M price change	-21.57%
1M total return	-21.57%
1Y price change	-54.89%
1Y return CAGR	-54.91%
1Y total return	-54.89%
20-day SMA	$1.24
200-day SMA	$2.14
20Y price change	-90.46%
20Y return CAGR	-7.95%
20Y total return	-80.92%
3M price change	-39.09%
3M total return	-39.09%
3Y price change	-87.18%
3Y return CAGR	-49.57%
3Y total return	-87.18%
50-day SMA	$1.51
50-day SMA vs 200-day SMA	50under200
52-week high	$4.10
52-week high date	2025-12-16
52-week low	$1.15
52-week low date	2026-10-26
5Y price change	-95.45%
5Y return CAGR	-44.75%
5Y total return	-94.85%
6M price change	-47.83%
6M total return	-47.83%
All-time high	$57.80
All-time high date	2018-01-22
All-time low	$0.09
All-time low date	2001-02-02
Average true range (ATR)	$0.05
Average volume	114.9K
Beta (1Y)	1.25
Beta (2Y)	1.53
Beta (5Y)	0.84
Change from 52-week high	-70.98%
Change from 52-week low	3.48%
Change from all-time high	-97.92%
Change from all-time low	1,179.32%
Change from open	1.71%
Day's gap	-0.85%
Dollar volume	$22,304
High price	$1.22
Low price	$1.17
Monthly RSI	27.41
Open price	$1.17
Position in 52-week range	41.67%
Premarket change	0%
Premarket close	$1.18
Premarket price	$1.18
Previous close	$1.18
Price vs 150-day SMA	-36.31%
Price vs 20-day SMA	-3.3%
Price vs 200-day SMA	-43.82%
Price vs 50-day SMA	-20.32%
Relative volume	0.16
RSI	34.55
Sharpe ratio	-0.45
Sharpe ratio (3Y)	-0.64
Sharpe ratio (5Y)	-0.69
Sortino ratio	-0.81
Sortino ratio (3Y)	-0.97
Sortino ratio (5Y)	-1.01
Volume	18.7K
Weekly RSI	27.57
YTD price change	-62.5%
YTD total return	-62.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.3M
Float percentage	62.99%
Shares change (QoQ)	3.09%
Shares change (YoY)	2.4%
Shares held by insiders	9.56%
Shares held by institutions	19.05%
Shares outstanding	21.1M
Short % of float	5.22%
Short % of shares	3.28%
Short ratio	5.6 days

Deeper analysis on PETS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PETS report

Is a complete PETS research report available?

No complete published report is available for PetMed Express, Inc. (PETS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PetMed Express, Inc. (PETS)

Price

Financial snapshot

Fair-value bridge

Latest news · PETS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PETS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PETS

Frequently asked questions